Editing genes to fix genetic mutations could revolutionize how we treat disease, but gene editing research is only in early stages, and plenty still needs to learned before we know it's safe for widespread use.
In this episode of Limelight Alpha's Talking Stocks, 7Investing Lead Advisor, Maxx Chatsko, joins Todd Campbell to explains the pros and cons of gene editing. The duo discuss:
You can learn more about 7Investing here: https://7investing.com/subscribe/?referred_by_id=747
You can learn more about Limelight Alpha here: https://seekingalpha.com/author/limelight-alpha-management-partners/research
Follow Limelight Alpha on Twitter: @AlphaLimelight
Follow Maxx Chatsko on Twitter: @7MaxxChatsko
---
Support this podcast: https://podcasters.spotify.com/pod/show/limelight-alpha/support
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More